Evidence map›Paper›PMID 39648181›Full record

ArticleNeurochemical research2024

Neuroprotective Effects of STAT3 Inhibitor on Hydrogen Peroxide-Induced Neuronal Cell Death via the ERK/CREB Signaling Pathway.

Seul-Ki Kim, Yong-Jin Kwon, Eun-Bi Seo, Hyun-Seung Lee, Jie Ohn Sohn, Hyun Mu Shin, Sung Joon Kim, Sang-Kyu Ye

Abstract read
In one paragraph

Article in Neurochemical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Synergistic Effects of Anthocyanin-EnrichedFoods (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Seul-Ki KimDepartment of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Yong-Jin KwonDepartment of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Eun-Bi SeoDepartment of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Hyun-Seung LeeDepartment of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Jie Ohn SohnWide River Institute of Immunology, Seoul National University, Hongcheon, 25159, Republic of Korea.
Hyun Mu ShinWide River Institute of Immunology, Seoul National University, Hongcheon, 25159, Republic of Korea.
Sung Joon KimIschemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Sang-Kyu YeDepartment of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. sangkyu@snu.ac.kr.

Funding

Cooperative Research Program for Agriculture Science and Technology Development RS-2021-RD009467National Research Foundation of Korea (NRF) funded by the Korean governmen NRF-2022R1A2C1011914National Research Foundation of Korea (NRF) funded by the Korean government NRF-2018R1A5A2025964"World Class Plus Program" supervised by the Korea Institute for Advancement of Technology (KIAT). R&D, P0024366
6 · The paper itself

Abstract

This study investigates the neuroprotective potential of STAT3 inhibition in reducing oxidative stress-induced neuronal damage and apoptosis, a major factor contributing to the onset and progression of neurodegenerative diseases, including Alzheimer's disease (AD). Our findings demonstrate that STAT3 inhibitors significantly enhance cell survival and reduce apoptosis in SH-SY5Y cells exposed to hydrogen peroxide. These protective effects are mediated through the ERK/CREB signaling pathway rather than direct suppression of STAT3 phosphorylation. Further analysis revealed that the ERK pathway is a critical mediator of CREB activation following STAT3 inhibition. The protective effects of STAT3 inhibitors were significantly reduced in the presence of the ERK inhibitor PD98059, underscoring the importance of the ERK/CREB axis in neuroprotection. We observed that STAT3 inhibitors promote CREB phosphorylation, leading to the upregulation of immediate early genes such as c-Fos, c-Jun, Arc, Egr-1, NR4A1, and Homer1a, as well as BDNF. These genes are crucial for synaptic plasticity and long-term memory formation, suggesting that STAT3 inhibition may ameliorate cognitive impairments in neurodegenerative conditions. Our results highlight the potential of STAT3 inhibitors to counteract oxidative stress and enhance cognitive functions by modulating the ERK/CREB signaling pathway. These findings provide valuable insights into the molecular mechanisms of STAT3 inhibition and support its therapeutic potential for treating neurodegenerative diseases.

Indexed as

Cyclic AMP Response Element-Binding ProteinHydrogen PeroxideMAP Kinase Signaling SystemNeuronsNeuroprotective AgentsSTAT3 Transcription FactorApoptosisCell DeathCell Line, TumorCell SurvivalHumansOxidative StressSignal TransductionCREB1 protein, humanCyclic AMP Response Element-Binding ProteinHydrogen PeroxideNeuroprotective AgentsSTAT3 protein, humanSTAT3 Transcription FactorERK/CREB signaling pathwayImmediate early genesNeurodegenerative diseasesNeuroprotectionOxidative stressSTAT3 inhibition

Identifiers

PMID39648181
PMCPMC11625690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.